Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

PhRMA: resetting the conversation

A new requirement launched by US industry association PhRMA is mandating a minimum R&D spend by all members. The move sits at the core of the group’s campaign to revitalise the pharma sector’s public image and strengthen its stance on drug pricing, but can PhRMA truly reset the conversation?

Go Top